HOME › DRUGS › METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE
ACTIVE SUBSTANCE / INN

METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE

Brand name(s): SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE
FDA LISTED
NONE (TENTATIVE APPROVAL)
ANDA216885
ANDA217017
ACTIVE SUBSTANCE
Metformin Hydrochloride, Sitagliptin Phosphate
REGULATORS
FDA
SPONSORS / MAH
PRINSTON PHARMACEUTICAL INC, ZHEJIANG JIUZHOU BIOPHARMA CO., LTD.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDEANDA216885PRINSTON PHARMACEUTICAL INCNone (Tentative Approval)
SITAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA217017ZHEJIANG JIUZHOU BIOPHARMA CO., LTD.None (Tentative Approval)

FULL INTELLIGENCE ON METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →